Weil A Lorne

10% OwnerEnsysce Biosciences, Inc. (LACQ) · full profile →Form 4 · filed Jul 1, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2021Disposed to issuer(D)250K$0138K
Jun 30, 2021Grant(A)1.0M$1.00$1.0M1.0M
Jun 30, 2021Grant(A)730K$1.00$730K730K
Jun 30, 2021Grant(A)388K$1.00$388K388K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-015905) within minutes of acceptance. Every field above traces to the original document. Verify it directly: